Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADALIMUMAB vs INFLIXIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ADALIMUMAB vs INFLIXIMAB: Safety Overview

Metric ADALIMUMAB INFLIXIMAB
Total FAERS Reports 499,856 140,189
Deaths Reported 21,807 7,516
Death Rate 4.4% 5.4%
Hospitalizations 108,264 36,324
Average Patient Age 50.9 yrs 43.9 yrs
% Female Patients 67.6% 64.4%
Manufacturer Coherus BioSciences Inc Organon LLC
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status Prescription Prescription